In last trading session, Tempest Therapeutics Inc (NASDAQ:TPST) saw 0.74 million shares changing hands with its beta currently measuring -1.87. Company’s recent per share price level of $0.86 trading at -$0.05 or -5.14% at ring of the bell on the day assigns it a market valuation of $37.55M. That closing price of TPST’s stock is at a discount of -597.67% from its 52-week high price of $6.00 and is indicating a premium of 18.6% from its 52-week low price of $0.70.
For Tempest Therapeutics Inc (TPST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.25 in the current quarter.
Tempest Therapeutics Inc (NASDAQ:TPST) trade information
Upright in the red during last session for losing -5.14%, in the last five days TPST remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $0.86 price level, adding 9.61% to its value on the day. Tempest Therapeutics Inc’s shares saw a change of 3.10% in year-to-date performance and have moved -7.70% in past 5-day. Tempest Therapeutics Inc (NASDAQ:TPST) showed a performance of -2.55% in past 30-days.
Tempest Therapeutics Inc (TPST) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 62.66% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 29.54% while estimates for its earnings growth in next 5 years are of 12.39%.
Tempest Therapeutics Inc (NASDAQ:TPST)’s Major holders
BLACKROCK INC. is the top institutional holder at TPST for having 0.55 million shares of worth $1.21 million. And as of 2024-06-30, it was holding 2.4747 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 0.43 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.9426 of outstanding shares, having a total worth of $0.95 million.
On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 226.2 shares of worth $0.19 million or 0.52% of the total outstanding shares. The later fund manager was in possession of 174.01 shares on Sep 30, 2024 , making its stake of worth around $0.15 million in the company or a holder of 0.40% of company’s stock.
